First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

BACKGROUND: Lung cancer is a malignant carcinoma which has the highest morbidity and mortality in Chinese population. Gefitinib, a tyrosine kinase (TK) inhibitor of epidermal growth factor receptor (EGFR), displays anti-tumor activity. The present data regarding first-line treatment with single agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yong-Mei, Geng, Yi-Ting, Shao, Yong-Feng, Hu, Xiao-Li, Li, Wei, Shu, Yong-Qian, Wang, Zhao-Xia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954881/
https://www.ncbi.nlm.nih.gov/pubmed/20843324
http://dx.doi.org/10.1186/1756-9966-29-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954881/
https://www.ncbi.nlm.nih.gov/pubmed/20843324
http://dx.doi.org/10.1186/1756-9966-29-126

Ejemplares similares